The neuroprotective effect of olanzapine.
Yulug
Burak
B
Bakar
Mustafa
M
Ozan
Erol
E
D000704:Analysis of Variance; D000818:Animals; D001569:Benzodiazepines / Q000627:therapeutic use*; D020520:Brain Infarction / Q000517:prevention & control*; D004305:Dose-Response Relationship, Drug; D004341:Drug Evaluation; D020244:Infarction, Middle Cerebral Artery / Q000150:complications; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D018696:Neuroprotective Agents / Q000627:therapeutic use*; D000077152:Olanzapine; D013778:Tetrazolium Salts
D018696:Neuroprotective Agents; D013778:Tetrazolium Salts; D001569:Benzodiazepines; C009591:triphenyltetrazolium; D000077152:Olanzapine